ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

INDV Indivior Plc

1,408.00
8.00 (0.57%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BN4HT335 ORD USD0.50
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  8.00 0.57% 1,408.00 1,403.00 1,414.00 1,426.00 1,365.00 1,400.00 660,233 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.09B 2M 0.0148 952.03 1.91B
Indivior Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 1,400p. Over the last year, Indivior shares have traded in a share price range of 1,128.00p to 1,927.00p.

Indivior currently has 135,272,708 shares in issue. The market capitalisation of Indivior is £1.91 billion. Indivior has a price to earnings ratio (PE ratio) of 952.03.

Indivior Share Discussion Threads

Showing 4176 to 4198 of 4425 messages
Chat Pages: 177  176  175  174  173  172  171  170  169  168  167  166  Older
DateSubjectAuthorDiscuss
27/4/2023
13:44
Must be missing something, operating profit now to be less than FY22....I'd pencilled in $239m now it's less than $212m.Haven't digested all of the update yet just skimmed through so more informed opinions welcome, thanks.
disc0dave45
27/4/2023
12:29
Stellar results imvho. dyor & gla.
casholaa
25/4/2023
21:28
We're going to Las Vegas... get your jumpsuits cleaned.
casholaa
19/4/2023
11:16
Thank you W. I suspect it's news about the dual-listing.
casholaa
19/4/2023
10:56
Calendar


April/27 | 12:00pm Earnings Release


Perhaps they be knowing something

waldron
19/4/2023
10:36
For what though? What's the positive?
tommibone
18/4/2023
10:37
I think Blackrock picked up a few too from the rns yesterday
casholaa
18/4/2023
09:11
Roivant Sciences is Two Seas second largest holding and has just received a bid from Merck.Clearly,Two Seas think that there are reasons to believe that Indivior could be in the headlines.
steeplejack
18/4/2023
08:37
Two Seas Capital now has an interest of over 10%.Formerly known as Kairos Capital Management,they announced a holding of around 5% back 2020.

Two Seas Capital LP seeks to generate outsized, uncorrelated returns through investments in events with a legal or regulatory catalyst.Looks like this hedge fund hopes to benefit from volatility on the back of impending legal proceedings.

steeplejack
31/3/2023
14:09
They'd be daft not to start a further buyback at these share price levels, the share price appears to me to be at around the level it was at the start of October 2022.
casholaa
31/3/2023
08:54
That's true and a 3% holding in 'financial instruments' confirms as much.
steeplejack
30/3/2023
20:31
I find these brokers to be only intermediate holders. this is not really investment. same across many UK stocks
dealy
30/3/2023
16:18
Morgan Stanley continues to sell.Soon be under 3% of the ord equity……but it has financial instruments (CFDs i presume) giving a total holding of a bit over 6%.
steeplejack
30/3/2023
09:40
very low volume last 2 days. most other small / mid caps have bounced. catch up opportunity here
dealy
29/3/2023
18:16
fair comment
dealy
29/3/2023
13:58
Thereagain,GW Phamaceuticals abandoned AIM a few years back and listed on Nasdaq and was then taken over by Jazz Pharmaceuticals in 2021.Since MIFID2,research coverage for small,mediumUK companies (on the AIM market in particular) has diminished.Indivior is a FT250 constituent but it could well attract better research coverage in the USA and there are currency considerations.US funds might well be reticent to purchase sterling denominated stocks or pay UK government stamp duty for that matter.In any event,Indivior’;s main market is the US and anything which makes the stock more accessible to US investors is eminently sensible.Nowadays,global markets would suggest that things on different exchanges get pretty much equalised but there are clear investor relations advantages in being a quoted vehicle in your primary market.As for the good old UK LSE,the daily traded turnover in heavyweights like Amazon and Apple regularly exceeds the total daily turnover on the UK market.
steeplejack
29/3/2023
09:43
just taken up my fist position in this for 2 years.
dealy
27/3/2023
15:24
I have given up using reasoning
dealy
27/3/2023
13:03
But the opioid crisis in the US is where most of the treatment is delivered. Surely the relevance of the market will aid to this?
tommibone
25/3/2023
17:28
The AIM / UK Ad Tech company Tremor made a big song and dance about how an additional Nasdaq listing would boost its valuation. Since then its shares are down 75%. Clearly it had no positive effect. In general US listings of small / mid caps do not offer higher valuations than the uk. The hurdles and headwinds are the same
dealy
23/3/2023
13:03
Get yourself back up there, give us some g-force toward the sky!
casholaa
22/3/2023
10:45
They stated dual-listing will be in the Spring.
casholaa
21/3/2023
14:52
Spring started yesterday and runs to 21 June. Also, I think it's about to start gaining ground again but the 'market' rarely agrees with me so dyor + gla
casholaa
Chat Pages: 177  176  175  174  173  172  171  170  169  168  167  166  Older

Your Recent History

Delayed Upgrade Clock